StockGlow

Antengene Corporation Limited (6996.HK)

Antengene Corporation Limited, a clinical-stage APAC biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.

3.87-0.03%Healthcare
Compare 6996.HK with
StockGlow Score
29
Leaning Bearish
BearishBullish
1 year ago-19.0%

The outlook

Antengene Corporation Limited currently reads as leaning bearish based on below its 50- & 200-day averages, 21% of the way from its 52-week low to high, avg target +31% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range21% of the way from its 52-week low to high
Price targetAvg target +31% vs current price
Market cap
$2.62B
52-wk high
8.16
52-wk low
2.76
50-day avg
3.94
200-day avg
4.29
Trailing P/E
—

Similar stocks

2126.HKJW (Cayman) Therapeutics Co. Ltd$1.53-2.55%6998.HKEdding Genor Group Holdings Limited$1.65-3.51%6855.HKAscentage Pharma Group International$34.40-3.43%1167.HKJacobio Pharmaceuticals Group Co., Ltd.$4.73-2.07%9995.HKRemeGen Co., Ltd.$79.40-4.05%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy